Skip to content

Clinical trials

Completed Lung Diseases, Interstitial trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Completed Country / region: France Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20121
20131
20141
20161
20175
20181
20193
20205
20226
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim7
Assistance Publique - Hôpitaux de Paris3
Centre Hospitalier Universitaire de Nice2
Hospices Civils de Lyon2
University Hospital, Montpellier2
Actelion1
Bristol-Myers Squibb1
Centre Hospitalier Metropole Savoie1
Centre Hospitalier Universitaire de Saint Etienne1
Dieulefit Santé Centre de Réadaptation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial29
Idiopathic Pulmonary Fibrosis6
Pulmonary Fibrosis6
Arthritis, Rheumatoid2
Pulmonary Disease, Chronic Obstructive2
Sarcoidosis2
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
COVID-191
Connective Tissue Diseases1
Disease1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.